Jay R. Kostman

4.9k total citations
92 papers, 3.3k citations indexed

About

Jay R. Kostman is a scholar working on Virology, Epidemiology and Hepatology. According to data from OpenAlex, Jay R. Kostman has authored 92 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Virology, 38 papers in Epidemiology and 34 papers in Hepatology. Recurrent topics in Jay R. Kostman's work include HIV Research and Treatment (38 papers), Hepatitis C virus research (34 papers) and HIV/AIDS drug development and treatment (19 papers). Jay R. Kostman is often cited by papers focused on HIV Research and Treatment (38 papers), Hepatitis C virus research (34 papers) and HIV/AIDS drug development and treatment (19 papers). Jay R. Kostman collaborates with scholars based in United States, Qatar and Canada. Jay R. Kostman's co-authors include Luis J. Montaner, Vincent Lo Re, Karam Mounzer, Emmanouil Papasavvas, Livio Azzoni, T L Stull, Jihed Chehimi, John J. LiPuma, Thomas D. Edlind and Giorgio Trinchieri and has published in prestigious journals such as Nature Communications, Blood and Annals of Internal Medicine.

In The Last Decade

Jay R. Kostman

89 papers receiving 3.3k citations

Peers

Jay R. Kostman
Amy Weintrob United States
Andrea Kovács United States
Charles B. Hicks United States
Sven A. Danner Netherlands
Jay R. Kostman
Citations per year, relative to Jay R. Kostman Jay R. Kostman (= 1×) peers Giuliano Rizzardini

Countries citing papers authored by Jay R. Kostman

Since Specialization
Citations

This map shows the geographic impact of Jay R. Kostman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay R. Kostman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay R. Kostman more than expected).

Fields of papers citing papers by Jay R. Kostman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay R. Kostman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay R. Kostman. The network helps show where Jay R. Kostman may publish in the future.

Co-authorship network of co-authors of Jay R. Kostman

This figure shows the co-authorship network connecting the top 25 collaborators of Jay R. Kostman. A scholar is included among the top collaborators of Jay R. Kostman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay R. Kostman. Jay R. Kostman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Re, Vincent Lo, Dena M. Carbonari, Craig Newcomb, et al.. (2025). Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy. Open Forum Infectious Diseases. 12(9). ofaf571–ofaf571.
2.
Weinstein, Erica J, Dena M. Carbonari, Craig Newcomb, et al.. (2025). Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines. Open Forum Infectious Diseases. 12(5). ofaf102–ofaf102.
3.
Giron, Leila B., Clovis S. Palmer, Qin Liu, et al.. (2021). Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nature Communications. 12(1). 3922–3922. 37 indexed citations
4.
Papasavvas, Emmanouil, Livio Azzoni, Amélie Pagliuzza, et al.. (2020). Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial. AIDS Research and Human Retroviruses. 37(6). 433–443. 8 indexed citations
5.
Gowda, Charitha, Todd T. Brown, Charlene Compher, et al.. (2016). Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS. 30(16). 2519–2528. 3 indexed citations
6.
Byrne, Dana, Craig Newcomb, Dena M. Carbonari, et al.. (2014). Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. Journal of Hepatology. 61(2). 210–218. 25 indexed citations
7.
Goetz, Matthew Bidwell, Robert Leduc, Jay R. Kostman, et al.. (2010). HIV Replication Capacity Is an Independent Predictor of Disease Progression in Persons With Untreated Chronic HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(4). 472–479. 5 indexed citations
8.
Raymond, Andrea, Aidan S. Hancock, Malik Yousef, et al.. (2009). Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance. The Journal of Immunology. 182(7). 4459–4470. 76 indexed citations
9.
Goetz, Matthew Bidwell, Robert Leduc, Jay R. Kostman, et al.. (2009). Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(3). 259–266. 42 indexed citations
10.
Re, Vincent Lo, Valerianna Amorosa, A. Russell Localio, et al.. (2008). Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes. Clinical Infectious Diseases. 48(2). 186–193. 42 indexed citations
11.
Chehimi, Jihed, Livio Azzoni, Costin Tomescu, et al.. (2007). Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment. The Journal of Immunology. 179(4). 2642–2650. 71 indexed citations
12.
Papasavvas, Emmanouil, Jay R. Kostman, Brian Thiel, et al.. (2006). HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption. Journal of Clinical Immunology. 26(1). 40–54. 15 indexed citations
13.
Papasavvas, Emmanouil, Junwei Sun, Qi Luo, et al.. (2005). IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes. The Journal of Immunology. 175(8). 5532–5540. 11 indexed citations
14.
Bisson, Gregory P., Brian L. Strom, Robert Gross, et al.. (2005). Effect of GB virus C viremia on HIV acquisition and HIV set-point. AIDS. 19(16). 1910–1912. 10 indexed citations
15.
Re, Vincent Lo, Leanne B. Gasink, Jay R. Kostman, Debra G. B. Leonard, & Robert Gross. (2004). Natural History of Patients with Low-Level HIV Viremia on Antiretroviral Therapy. AIDS Patient Care and STDs. 18(8). 436–442. 6 indexed citations
16.
Bräu, Norbert, M. Rodríguez‐Torres, Maurizio Bonacini, et al.. (2004). Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon α-2b+ full-course vs. 16-week delayed ribavirin. Hepatology. 39(4). 989–998. 62 indexed citations
17.
Chehimi, Jihed, Donald E. Campbell, Livio Azzoni, et al.. (2002). Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals. The Journal of Immunology. 168(9). 4796–4801. 286 indexed citations
18.
Azzoni, Livio, Emmanouil Papasavvas, Jihed Chehimi, et al.. (2002). Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate Immunity. The Journal of Immunology. 168(11). 5764–5770. 116 indexed citations
19.
Axelrod, Peter, et al.. (1994). Investigation of a Pseudo-Outbreak of Orthopedic Infections Caused by Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology. 15(10). 652–657. 10 indexed citations
20.
Kostman, Jay R., et al.. (1991). Infections with Chryseomonas luteola (CDC Group Ve-1) and Flavimonas oryzihabitans (CDC Group Ve-2) in Neurosurgical Patients. Clinical Infectious Diseases. 13(2). 233–236. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026